Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):784-792. doi: 10.1016/j.ijrobp.2017.03.019. Epub 2017 Mar 18.
To determine the patterns of adjuvant chemoradiotherapy use in elderly patients treated with definitive surgical resection for squamous cell carcinoma of the head and neck with extracapsular extension (ECE) or positive margins and determine whether an association with overall survival (OS) exists with adjuvant concurrent chemoradiotherapy (CRT).
The National Cancer Database was queried to identify patients with SCC of the oral cavity, oropharynx, larynx, and hypopharynx who were treated with primary definitive surgery and adjuvant radiation therapy between 2004 and 2012. For elderly patients (aged >70 years) with pathology revealing ECE or positive margin, the benefit of concurrent chemotherapy was explored using multivariable Cox proportional hazards modeling.
A total of 7349 patients were identified meeting study criteria, of whom 1187 were elderly (aged >70 years) with a median follow-up of 30.6 months. Of these elderly patients, 445 had ECE or positive margin and represent the study population, of whom 187 (42%) received CRT. Delivery of CRT in this cohort increased over the study period, and intensity modulated radiation therapy was associated with increased use of CRT (odds ratio 2.07; P=.004). Increasing age was associated with reduced use of CRT (odds ratio 0.88; P<.001). Chemoradiotherapy was associated with a significant improvement in OS on multivariable analysis (hazard ratio 0.74; P=.04) and a trend toward significance on inverse propensity score analysis (hazard ratio 0.78; P=.051). Three-year OS was 53.8% in the CRT group, compared with 44.6% in the adjuvant radiation therapy-alone patients.
The use of adjuvant CRT is increasing among elderly patients with resected squamous cell carcinoma of the head and neck exhibiting ECE or positive margins. Chemoradiotherapy was associated with an improvement in OS on multivariable analysis but not propensity-weighted analysis. Among fit elderly patients with ECE or positive margins after definitive surgical resection, concurrent chemotherapy can be carefully considered.
确定伴有或不伴有包膜外侵犯(ECE)或切缘阳性的头颈部鳞状细胞癌(HNSCC)老年患者接受根治性手术切除后接受辅助放化疗的模式,并确定辅助同期放化疗(CRT)与总生存(OS)之间是否存在关联。
国家癌症数据库(National Cancer Database)被查询,以确定 2004 年至 2012 年间接受原发根治性手术和辅助放疗的口腔、口咽、喉和下咽 SCC 患者。对于病理显示 ECE 或切缘阳性的老年患者(年龄>70 岁),使用多变量 Cox 比例风险模型探讨同期化疗的获益。
共确定了 7349 名符合研究标准的患者,其中 1187 名年龄>70 岁,中位随访时间为 30.6 个月。在这些老年患者中,445 名患者有 ECE 或切缘阳性,占研究人群的 42%,其中 187 名(42%)接受了 CRT。在该队列中,CRT 的应用随着研究时间的推移而增加,调强放疗与 CRT 的应用增加相关(比值比 2.07;P=.004)。年龄的增加与 CRT 的应用减少相关(比值比 0.88;P<.001)。多变量分析显示,放化疗与 OS 显著改善相关(风险比 0.74;P=.04),在逆倾向评分分析中呈显著趋势(风险比 0.78;P=.051)。CRT 组的 3 年 OS 为 53.8%,而单纯辅助放疗组为 44.6%。
在接受根治性手术切除且伴有 ECE 或切缘阳性的头颈部鳞状细胞癌老年患者中,辅助 CRT 的应用正在增加。放化疗与多变量分析时 OS 改善相关,但与倾向评分加权分析无关。对于 ECE 或切缘阳性的根治性手术后的老年患者,如果身体状况良好,可以考虑同期化疗。